Clinical Trial
NCT05987423 Recruiting, Active
A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease
A Phase III, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Participants With Moderate-To-Severe Thyroid Eye Disease
Disease
Disease type
Other
Patient type
Adult
Children
Inclusion / Exclusion
Funding
private
Members involved
ERN EYE member investigating site
HCP : Principal investigators
Charité – Universitätsmedizin Berlin, Germany
Adress
Charitépl. 1
10117 Berlin
Germany
Eye Center, University Hospital Freiburg, Germany
Adress
Killianstraße 5
79106 Freiburg im Breisgau
Germany
Fondazione Policlinico Universitario A. Gemelli – Roma, Italy
Adress
Via della Pineta Sacchetti, 217
168 Roma RM
Italy